STOCKSCREENR
Log In

HCAT

NASDAQ

Health Catalyst, Inc.

$1.17-0.04(-3.70%)Mkt Cap: $86.10M

Key Stats

Market Cap

$86.10M

P/E Ratio

-0.46

EPS

$-2.55

Dividend Yield

0.00%

52-Week Range

$1.16 — $5.06

Volume

1.49M

Avg Volume

829.49K

Beta

1.78

Valuation

P/E (TTM)

-0.46

Forward P/E

3.36

PEG Ratio

0.01

P/S (TTM)

0.30

P/B (TTM)

0.38

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.55%

ROA (TTM)

-0.35%

ROIC

—

Gross Margin

0.49%

Operating Margin

-0.52%

Net Margin

—

Debt/Equity

0.08

Current Ratio

1.89

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.28%

EPS Growth (5Y)

+0.16%

Sales Growth (3Y)

+0.08%

Sales Growth (5Y)

+0.15%

EPS Est (This Year)

$0.35

EPS Est (Next Year)

$0.43

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$1.35

Analyst Consensus

Price Target Range

$3.00$4.50$5.00
LowMedianHigh

Consensus Target: $4.25(263.2% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

70.73M

Float

62.38M

Free Float %

88.20%

About

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

NASDAQ

IPO Date

2019-07-25

Employees

1500

CEO

Benjamin Albert

Index Membership

—

Website

https://www.healthcatalyst.com

Health Catalyst, Inc. (HCAT) is a healthcare company in the medical - healthcare information services industry listed on the NASDAQ. With a market capitalization of $86.10M, a P/E ratio of -0.46, HCAT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HCAT against other stocks using dozens of fundamental and technical filters.

Similar Stocks

CTEV

Claritev Corporation

$16.92

-3.86%

$280.07M

ADK.V

DIAGNOS Inc.

$0.29

-1.69%

$29.54M

SOPH

SOPHiA GENETICS S.A.

$5.00

+1.83%

$358.34M

CARL

CARLSMED, INC.

$11.70

+0.00%

$312.76M

ONMD

OneMedNet Corporation

$0.76

-5.20%

$24.97M

SLP

Simulations Plus, Inc.

$11.92

-1.65%

$240.15M

Frequently Asked Questions

What is Health Catalyst, Inc.'s P/E ratio?

Health Catalyst, Inc. (HCAT) has a trailing twelve-month (TTM) P/E ratio of -0.46. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Health Catalyst, Inc. pay a dividend?

No, Health Catalyst, Inc. (HCAT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Health Catalyst, Inc.'s market cap?

Health Catalyst, Inc. (HCAT) has a market capitalization of $86.10 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.